IRadimed Corporation
IRadimed Corporation（IRMD）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
irmd · 股价预测 · 2 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 2 位华尔街分析师
Buy
2 位分析师
共识
评级分布
12 个月目标价
High
$120
Consensus
$120
+27.1% upside
Low
$120
Median: $120 · Last Close: $94.39
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $95.96 | ↑ 1.66% |
1-day model range: $95.6–$96.32. Peak: $96.32 (+1.66%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $117 | +24.1% |
| 2028 | $133 | +40.6% |
| 2029 | $142 | +50.9% |
| 2030 | $148 | +56.9% |
| 2031 | — | +60.4% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · IRMD · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2025-02-14 | Roth MKM | Maintains | Buy→Buy |
| 2024-08-02 | Roth MKM | Maintains | Buy→Buy |
| 2021-08-02 | Roth Capital | Maintains | Buy→Buy |
| 2017-07-31 | Roth Capital | Upgrade ↑ | Neutral→Buy |
| 2016-10-05 | Roth Capital | Downgrade ↓ | Buy→Neutral |
| 2016-04-04 | Roth Capital | Maintains | Buy→Buy |
| 2015-06-16 | Roth Capital | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on IRadimed Corporation (IRMD) stock. Of the recent 7 rating actions, 1 were upgrades and 1 were downgrades. 2 analysts currently cover IRMD.
分析师推荐趋势
IRMD analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$91M
↓ 19.0% YoY
Revenue Next Year
$101M
↑ 10.6% YoY
EPS This Year
$2.08
EPS Next Year
$2.35
↑ 13.5% YoY
EPS ForecastReported vs Estimated
Analysts forecast IRMD EPS of $2.08 for the current fiscal year, based on estimates from 1 analysts. The IRMD revenue forecast is $91M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
IRMD 股价预测由两类独立数据源支撑：来自 2 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。IRMD 的共识目标价为 $120.00（+27.1% 上行空间），分析师共识为 Buy。
IRMD 的短期预测（明日）为 $95.96（+1.66%）。 IRMD 对 2027 年的股价预测均值为 $117。 IRMD 对 2030 年的预测区间为 $142–$154。
IRadimed Corporation 在 NASDAQ 上市，代码 IRMD。IRMD 在 2027 年的整体展望偏积极，在覆盖分析师中约 100% 对应 Buy 共识。
常见问题
IRMD 预测 · 8 个问题根据 2 位华尔街分析师，IRMD 的 12 个月平均目标价为 $120.00，最高 $120.00、最低 $120.00。若有图表，中位目标价可在上方查看。相对当前价 $94.39，隐含约 +27.1% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.